Clinical Research Unit at the Montreal Neurological Institute & Hospital
3801 University Street, suite 207 H3A 2B4 Montreal, QC, Canada

Tune in at noon on Thursday, November 19 for a special webinar from the Michael J. Fox Foundation covering the latest in Parkinson's research, including new treatments. Register at the link below.

My mother was diagnosed with ALS by Dr. Genge (Director of the CRU). I accompanied her to all her appointments at The Neuro, so I know how much hope patients have that their treatment will make them better. Working at the CRU, I feel that I am part of the chain of people helping to move research forward for neurological diseases. I’d like to think that in my lifetime, we will see progress so that those affected can go on to live a full life, like we have thanks to treatments... for HIV. It would be amazing to know that I contributed to that, explains Randy Jacinto, medical research program coordinator at the CRU. Randy is in charge of processing blood samples and preparing them to be sent to the organization managing the trial. Randy has a BSc in microbiology and a graduate certificate in microbiology and molecular biotechnology. Before coming to the CRU he worked in pre-clinical trials running toxicology tests. __ Ma mère a reçu un diagnostic de SLA par la Dre Genge (directrice de l’URC). Je l'ai accompagnée à tous ses rendez-vous au Neuro, donc je sais à quel point les patients espèrent que leurs traitements vont les aider. En travaillant à l’URC, je sens que je fais partie de la chaîne des individus qui contribuent à faire avancer la recherche sur les maladies neurologiques. J’espère que de mon vivant, nous verrons des progrès pour que les personnes touchées puissent vivre une longue vie, comme c’est le cas grâce aux traitements contre le VIH. Ce serait merveilleux de savoir que j'ai contribué à cela , explique Randy Jacinto, coordonnateur dans le programme de recherche médicale à l'URC. Randy est titulaire d'un BSc en microbiologie et d'un certificat d'études supérieures en microbiologie et biotechnologie moléculaire. Avant de rejoindre l’URC, il a exécuté des tests de toxicologie dans des essais précliniques. The Neuro McGill Faculty of Medicine and Health Sciences Centre universitaire de santé McGill - McGill University Health Centre

Our friends at McGill Cares are supporting informal caregivers with a series of expert talks about dementia. Join them today at noon for a 30-minute talk with Dr. Serge Gauthier about the latest and most promising research on the detection and treatment of Alzheimer’s disease. Dr. Gauthier is the Director of the Alzheimer’s Disease Research Unit of the McGill University Research Centre for Studies in Aging. To register, go to bit.ly/mcgillcaresweb. The CRU is taking part in ...a pan-Canadian study to evaluate better ways to detect Alzheimer’s early. To learn more, visit https://cru.mcgill.ca/dementia. #neuro #neuroscience #neurologicaldisorder #research #clinicalresearch #montrealneuro #clinicalresearchunit #mcgill #mni #clinicaltrials #cru #theneuro #alzheimers #dementia #ftd#LetsTalkAboutDementia

Proud to announce that The Neuro is rated No. 1 in Canada among the top 100 neurology centres in the world in Newsweek's annual ranking! Congratulations to Director Dr. Guy Rouleau and all the clinicians, allied health professionals and support staff that provide exceptional care to patients and make The Neuro an outstanding place to work. bit.ly/newsweektop100 ___ Fiers d'annoncer que le Neuro est classé numéro 1 au Canada parmi les 100 meilleurs centres spécialisés en ne...urologie au monde dans le palmarès annuel de Newsweek! Félicitations au directeur Dr Guy Rouleau, ainsi qu'à tous les cliniciens, professionnels paramédicaux et personnel de soutien qui offrent des soins exceptionnels aux patients et font du Neuro un lieu de travail remarquable. bit.ly/newsweektop100 #neuro #neuroscience #neurologicaldisorder #research #clinicalresearch #openscience #montrealneuro #clinicalresearchunit #mcgill #mni #clinicaltrials #cru #theneuro #neurology #newsweek #top100hospitals The Neuro Centre universitaire de santé McGill - McGill University Health Centre McGill Faculty of Medicine and Health Sciences

At the moment, there is no approved medication to slow the progression of Parkinson’s disease (PD). The CRU is participating in the REASON clinical trial that is studying an investigational drug that may be able to slow or stop the progression of PD. If you are between 35 and 80 years old, and have been diagnosed with PD within the last 7 years, you may be eligible to take part. To make an informed choice about participating in this or other Parkinson’s trials at the CRU, ...visit cru.mcgill.ca/parkinson. ____ Pour le moment, il n’existe aucun médicament approuvé pour ralentir la progression de la maladie de Parkinson (MP). L'URC participe à l'essai clinique REASON qui étudie un médicament expérimental qui pourrait être capable de ralentir ou d'arrêter la progression de la MP. Si vous avez entre 35 et 80 ans et que vous avez reçu un diagnostic de MP au cours des 7 dernières années, vous pourriez être admissible à participer. Pour faire un choix éclairé de participer à cet essai ou à d’autres essais sur la maladie de Parkinson à l'URC, visitez cru.mcgill.ca/fr/troubles-du-mouvement/. #TheNeuro #Parkinsons #ParkinsonsDisease #neurodegenerativediseases #PD #Together4PD #neuro #neuroscience #neurologicaldisorder #research #clinicalresearch #drugdevelopment #openscience #clinicaltrials The Neuro Centre universitaire de santé McGill - McGill University Health Centre McGill Faculty of Medicine and Health Sciences